Sinovac director Qiu Yu Min files Form 3

SINOVAC BIOTECH LTD director Qiu Yu Min filed an initial Form 3, which is a required disclosure of insider status.

Accepted by SEC EDGAR 03/18/2026 - 08:20 AM EDT

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

SINOVAC BIOTECH LTD director Qiu Yu Min filed an initial Form 3, which is a required disclosure of insider status. This filing reports no transactions in the company’s securities and no derivative holdings, serving only to register Qiu Yu Min as a reporting insider.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the SINOVAC BIOTECH (SVA) Form 3 for Qiu Yu Min show?

The Form 3 for SINOVAC BIOTECH (SVA) shows that Qiu Yu Min is a director and an insider. It reports no purchases, sales, or derivative positions, serving only as an initial ownership disclosure.

Did Qiu Yu Min buy or sell SINOVAC BIOTECH (SVA) shares in this Form 3?

No, this Form 3 for SINOVAC BIOTECH (SVA) reports zero transactions. The summary fields show no buys, no sells, and no derivative exercises, indicating it is purely an initial registration filing.

Why did SINOVAC BIOTECH (SVA) file a Form 3 for Qiu Yu Min?

SINOVAC BIOTECH (SVA) filed a Form 3 because Qiu Yu Min is a director and therefore a reporting insider. Form 3 establishes this status with the SEC, even when no transactions are reported.

Does the SINOVAC BIOTECH (SVA) Form 3 indicate any derivative holdings for Qiu Yu Min?

No, the Form 3 derivative summary for SINOVAC BIOTECH (SVA) is empty. It shows no options, warrants, or other derivative securities reported for Qiu Yu Min at the time of this filing.

What does a zero transaction count on the SINOVAC BIOTECH (SVA) Form 3 mean?

A zero transaction count on the SINOVAC BIOTECH (SVA) Form 3 means the insider has not reported any recent trades. It simply records insider status without changing the public float or signaling trading activity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

QIU YU MIN

(Last)

(First)

(Middle)

901, JIN BAO TOWER

89 JINBAO STREET, DONG CHENG

(Street)

BEIJING

100005

(City)

(State)

(Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
SINOVAC BIOTECH LTD [ SVA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Jia Zhao, Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR